Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer
Clinical trial NCT00996502 · TERMINATED
Trial details
- NCT number
- NCT00996502
- Sponsor
- Columbia University
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2010-03-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.